Table 4.
Venous Blood Gases in Protocol 2
| Trial | Condition | pH | pO2 (mmHg) | pCO2 (mmHg) | FO2Hb (%) |
|---|---|---|---|---|---|
| Time Control Exercise | Rest | 7.36±0.01 | 30.9±2.3 | 46.0±1.4 | 54.5±4.7 |
| 15% Ex Min 4 | 7.29±0.01* | 22.9±0.7* | 59.1±2.1* | 32.2±1.6* | |
| 15% Ex Min 6 | 7.29±0.01* | 22.4±0.7* | 59.0±2.0* | 31.2±1.3* | |
| Exercise then Occlusion | Rest | 7.37±0.01 | 26.1±1.2 | 45.0±1.6 | 45.0±3.0 |
| 15% Ex | 7.30±0.01* | 22.9±0.7* | 57.0±1.7* | 32.0±1.3* | |
| 15% Ex + Occlusion | 7.27±0.02* | 18.9±1.3*† | 57.5±3.6* | 22.4±2.7*† | |
| Occlusion then Exercise | Rest | 7.36±0.01 | 28.5±2.2 | 47.4±1.6 | 48.7±5.0 |
| Occlusion | 7.36±0.01 | 27.4±1.0 | 41.3±2.2* | 46.0±2.8 | |
| Occlusion+ 15% Ex | 7.35±0.01 | 24.2±0.9*† | 40.6±2.3* | 37.7±1.8*† |
P < 0.05 vs Rest;
P < 0.05 vs prior timepoint